Financhill
Sell
37

NRXP Quote, Financials, Valuation and Earnings

Last price:
$2.44
Seasonality move :
51.98%
Day range:
$2.34 - $2.46
52-week range:
$1.41 - $6.01
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
172.21x
P/B ratio:
--
Volume:
195.4K
Avg. volume:
506.3K
1-year change:
55.41%
Market cap:
$68.6M
Revenue:
--
EPS (TTM):
-$2.35

Earnings Data

Next earnings date for NRXP
Mar 17
2026
Most recent earnings per share
-$0.26
Missed by $0.25
(Nov 17/2025)
Consensus Estimate
-$0.02
(Nov 17/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NRXP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/17/2026 Q4 $9.3M -- -- -$0.06 --
11/17/2025 Q3 $6.1M $242K -$0.26 -$0.02 -$0.25
08/18/2025 Q2 -- -- -$0.98 -$0.23 -$0.75
05/14/2025 Q1 -- -- -$0.34 -$0.25 -$0.09
03/17/2025 Q4 -- -- -$0.77 -$0.37 -$0.40
11/18/2024 Q3 -- -- -$0.15 -$0.66 $0.51
08/14/2024 Q2 -- -- -$0.75 -$0.70 -$0.06
05/14/2024 Q1 -- -- -$0.74 -$0.55 -$0.19
03/28/2024 Q4 -- -- -$0.52 -$0.80 $0.28
11/13/2023 Q3 -- -- -$0.74 -- --
08/14/2023 Q2 -- -- -$1.19 -- --
05/16/2023 Q1 -- -- -$1.64 -- --
03/30/2023 Q4 -- -- -$1.54 -- --
11/14/2022 Q3 -- -- -$1.37 -- --
08/15/2022 Q2 -- -- -$1.06 -- --
05/16/2022 Q1 -- -- -$2.11 -- --
03/31/2022 Q4 -- -- -$5.24 -- --
11/16/2021 Q3 -- -- -$4.07 -- --
08/16/2021 Q2 -- -- -$65.14 -- --
03/31/2021 Q1 -- -- -$7.15 -- --
12/31/2020 Q4 -- -- -$10.50 -- --
09/30/2020 Q3 -- -- -$1.51 -- --
06/30/2020 Q2 -- -- $0.03 -- --
03/31/2020 Q1 -- -- $0.96 -- --
12/31/2019 Q4 -- -- -$0.03 -- --
09/30/2019 Q3 -- -- $0.10 -- --
06/30/2019 Q2 -- -- $0.25 -- --
03/31/2019 Q1 -- -- $0.21 -- --
12/31/2018 Q4 -- -- $0.03 -- --
09/30/2018 Q3 -- -- $0.03 -- --
06/30/2018 Q2 -- -- -$0.01 -- --
03/31/2018 Q1 -- -- $0.02 -- --
12/31/2017 Q4 -- -- -$0.11 -- --
09/30/2017 Q3 -- -- -$0.00 -- --

NRX Pharmaceuticals, Inc. Earnings Questions

  • How Much did NRX Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    NRX Pharmaceuticals, Inc. reported $242K worth of top line sales in its most recent quarter.

  • Did NRX Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    NRX Pharmaceuticals, Inc. announced earnings per share of -$0.26 which represents a miss of analyst forecast a -$0.02 per share.

  • Is NRX Pharmaceuticals, Inc. Profitable?

    NRX Pharmaceuticals, Inc. reported $104K that represents $0.00 per share over the last quarter.

  • What is the Analyst Consensus for NRX Pharmaceuticals, Inc. EPS Next Year?

    NRX Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$2.36 per share to -$1.93 per share next year representing a decrease of -43.66%.

  • When is NRX Pharmaceuticals, Inc.'s Earnings Date?

    NRX Pharmaceuticals, Inc.'s next earnings date is March 17, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock